Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Citi
US Army
Johnson and Johnson
Julphar
Moodys
AstraZeneca
Harvard Business School
Cantor Fitzgerald
Teva

Generated: October 22, 2017

DrugPatentWatch Database Preview

VEPESID Drug Profile

« Back to Dashboard

Which patents cover Vepesid, and what generic Vepesid alternatives are available?

Vepesid is a drug marketed by Dava Pharms Inc and Corden Pharma and is included in two NDAs.

The generic ingredient in VEPESID is etoposide. There are eleven drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the etoposide profile page.

Summary for Tradename: VEPESID

US Patents:0
Applicants:2
NDAs:2
Bulk Api Vendors: see list41
Clinical Trials: see list23
Patent Applications: see list9,898
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:VEPESID at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dava Pharms Inc
VEPESID
etoposide
CAPSULE;ORAL019557-001Dec 30, 1986DISCNYesNo► Subscribe► Subscribe► Subscribe
Dava Pharms Inc
VEPESID
etoposide
CAPSULE;ORAL019557-002Dec 30, 1986DISCNYesNo► Subscribe► Subscribe► Subscribe
Corden Pharma
VEPESID
etoposide
INJECTABLE;INJECTION018768-001Nov 10, 1983DISCNYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: VEPESID

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Dava Pharms Inc
VEPESID
etoposide
CAPSULE;ORAL019557-001Dec 30, 1986► Subscribe► Subscribe
Corden Pharma
VEPESID
etoposide
INJECTABLE;INJECTION018768-001Nov 10, 1983► Subscribe► Subscribe
Dava Pharms Inc
VEPESID
etoposide
CAPSULE;ORAL019557-002Dec 30, 1986► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

McKesson
Cerilliant
Argus Health
Julphar
Cipla
Fuji
US Department of Justice
Express Scripts
Federal Trade Commission
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot